TD Asset Management’s Enliven Therapeutics ELVN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.34M Buy
+66,906
New +$1.34M ﹤0.01% 1022